Sacituzumab tirumotecan is under clinical development by Merck and currently in Phase II for Gastrointestinal Tract Cancer.

Envafolimab is under clinical development by Alphamab Oncology and currently in Phase I for Gastrointestinal Tract Cancer.

Image courtesy of Ren Dodge/Carnegie Science shows Lactobacillus (red) in a certain part of the fruit fly gastrointestinal tract (blue/cyan). | Microbiology ...

Understanding the multiple causes of holiday-related digestive health issues is essential to clinicians in helping patients ...

Gastrointestinal motility refers to the contractions that propel food through the digestive tract, essential for the ...

Discover the top five reasons for bloating and learn effective solutions to relieve discomfort. Get expert tips for better ...

Cases of norovirus appear to be on the rise in various parts of the U.S., according to data from the Centers for Disease ...

“Chronic abdominal pain is complex because it involves multiple mechanisms, including inflammation, altered gut motility, and heightened sensitivity of the nervous system,” Muttenhalter told IE. “The ...

The rising prevalence of gastrointestinal disorders such as irritable bowel syndrome and Crohn's disease is driving the ...

New imaging technique able to identify early signs of graft-versus-host-disease in transplant patients. Read on!

Undiagnosed or untreated EPI could result in muscle loss since the patient isn’t absorbing the necessary nutrients.